The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor

Clinical Immunology

Volumn 95, Issue 2, 2000, Pages 117-123

  Schiffenbauer, Joel ^a   Streit, Wolfgang J ^a   Butfiloski, Edward ^a   Labow, Mark ^b   Edwards III, Carl ^c   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c AMGEN INC   (United States)

Author keywords

EAE; IL 1; Receptor; TNF

Indexed keywords

INTERLEUKIN 1 RECEPTOR; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; ENCEPHALOMYELITIS; GENE DELETION; GENE DISRUPTION; GENE INDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034028453     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4851     Document Type: Article

References (30)

1. Selmaj K., Raine C. S., Cross A. H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
2. Selmaj K., Papierz W., Glabinski A., Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56:1995;135-141.
3. Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
4. Kuroda Y., Shimamoto Y. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34:1991;159-164.
5. Crisi G. M., Santambrogio L., Hochwald G. M., Smith S. R., Carlino J. A., Thorecke G. J. Staphylococcal enterotoxin B and tumor necrosis factor-α-induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor-β and interleukin-10. Eur. J. Immunol. 25:1995;3035-3040.
6. Frei K., Eugster H., Bopst M., Constantinescu C. S., Lavi E., Fontana A. Tumor necrosis factor and lymphotoxin are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1997;2177-2182.
7. Liu J., Marino M. W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A. J., Old L., Bernard C. C. A. TNF is a potent anti-inflammatory cytokine in autoimmune mediated demyelination. Nature Med. 4:1998;78-83.
8. Vandenabeele P., Declercq W., Bayaert R., Fiers W. Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol. 5:1995;392-400.
9. Ostade X. V., Vandenabeele P., Everaerdt B., Loetscher H., Gentz R., Brockhaus M., Lesslauer W., Tavernier J., Brouckaert P., Fiers W. Human TNF mutants with selective activity on the p55 receptor. Nature. 361:1993;266-269.
10. Barbara J. A. J., Smith W. B., Gamble J. R., Ostade X. V., Vandenabeele P., Tavernier J., Lopez A. F. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMJO J. 13:1994;843-850.
11. Rothe J., Lessiauer W., Lötscher H., Lang Y., Koebel P., Köntgen F., Althage A., Zinkernagel R., Steimetz M., Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364:1993;798-800.
12. Pfeffer K., Matsuyama T., Kozndig T. M., Wakeham A., Kishihara K., Shahinian A., Wiegmann K., Ohashi P. S., Krönke M. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:1993;457-467.
13. Labow M., Shuster D., Zetterstrom M., Nunes P., Terry R., Cullinan E. B., Bartfai T., Solorzano C., Moldawer L. L., Chizzonite R., McIntyre K. W. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159:1997;2452-2461.
14. Erickson S. L., de Sauvage F. J., Kikly K., Carver-Moore K., Pitts-Meek S., Gillett N., Sheehan K. C. F., Schreiber R. D., Goeddel D. V., Moore M. W. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature. 378:1994;560-563.
15. Sheehan K. C. F., Pinckard J. K., Arthur C. D., Dehner L. P., Goeddel D. V., Schreiber R. D. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: Identification of a novel in vivo role for p75. J. Exp. Med. 181:1995;607-617.
16. Zheng L., Fisher G., Miller R. E., Peschon J., Lynch D. H., Lenardo M. J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:1995;348-351.
17. Tartaglia L. A., Goeddel D. V., Reynolds C., Figari I. S., Weber R. F., Fendly B. M., Paladino M. A. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:1993;4637-4641.
18. Peschon J. J., Torrance D. S., Stocking K. L., Glaccum M. B., Otten C., Willis C. R., Charrier K., Morrissey P. J., Ware C. B., Mohler K. M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:1998;943-952.
19. Douni E., Kollias G. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin α, or the p55TNF-R. J. Exp. Med. 188:1998;1343-1352.
20. Dinarello C. Role of interleukin-1 in infectious diseases. Immunol. Rev. 127:1992;119-132.
21. Streit W. J. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA 1-B4). J. Histochem. Cytochem. 38:1990;1683-1686.
22. Kusters S., Tiegs G., Alexopoulou L., Pasparakis M., Douni E., Kunstle G., Bluethmann H., Wendel A., Pfizenmaier K., Kollias G., Grell M. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 11:1997;2870-2878.
23. Alexopoulou L., Pasparakis M., Kollias G. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur. J. Immunol. 10:1997;2588-2592.
24. Tartaglia, L. A., Pennica, D., and Goeddel, D. V., Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem.268, 18542-18548, 1993.
25. Weiss T., Grell M., Hessabi B., Bourteele S., Muller G., Scheurich P., Wajant H. Enhancement of TNF receptor p60-Mediated cytotoxicity by TNF receptor p80. J. Immunol. 158:1997;2398-2404.
26. Eugster H. P., Frei K., Bachmann R., Bluethmann H., Lassman H., Fontana A. Severity of symptoms and demyelination in MOG induced EAE depends on TNFR1. Eur. J. Immunol. 29:1999;626-632.
27. Badovinac V., Mostarica-Stojkovic M., Dinarello C. A., Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J. Neuroimmunol. 85:1998;87-95.
28. Martin D., Near S. L. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61:1995;241-245.
29. Wiemann B., Van G. Y., Danilenko D. M., Yan Q., Matheson C., Munyakazi L., Ogenstad S., Starnes C. O. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist. Exp. Neurol. 149:1998;455-463.
30. Jacobs C. A., Baker P. E., Roux E. R., Picha K. S., Toivola B., Waugh S., Kennedy M. K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 146:1991;2983-2989.